CD2 and Splenomegaly: We have previously demonstrated in a model of DSS-induced colitis that, in contrast to CD2-Tff2 mice, Tff2-null counterparts develop massive splenomegaly by 19–21 days due to the expansion of splenic myeloid CD11b+Gr-1+ cells.